Harbor Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Harbor Capital Advisors's PFE Position: Q1 2026 in Review
Harbor Capital Advisors reduced its Pfizer (PFE) stake by 26% in Q1 2026, selling an estimated $632K and leaving 66,964 shares worth $1.88M. The position accounts for 0.15% of the portfolio, ranked #198.
Harbor Capital Advisors first reported a position in PFE in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.98M in Q1 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Harbor Capital Advisors held 66,964 shares of Pfizer worth $1.88M as of Q1 2026.
- Harbor Capital Advisors sold 23,754 Pfizer shares in Q1 2026, an estimated $632K.
- Pfizer made up 0.15% of Harbor Capital Advisors's portfolio in Q1 2026, its #198 holding.
- Harbor Capital Advisors first reported a position in Pfizer in Q1 2022 and has held it in 17 quarters since.
- Harbor Capital Advisors's Pfizer position peaked at $3.98M in Q1 2023.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.